Nurse Practitioner Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Kendall Bowler

Nurse Practitioner Charleston, SC Nurse Practitioner

NPI 1417736133 CMS profile 11522079

3531 Mary Ader Ave Ste A, Charleston, SC 29414

Open in the dashboard

General payments

$7,132

381 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kendall Bowler of Charleston, SC is reported in the CMS Open Payments database as having received $7,132 across 381 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,790 156
2024 General $3,684 199
2023 General $658 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kendall Bowler
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Kendall Bowler were reported at $2,790. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Kendall Bowler Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $0 $152 $48–$470 $149
2023 $658 $166 $54–$529 $160
2024 $3,684 $173 $55–$556 $164
2025 $2,790 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. AbbVie, Inc. $959 84 payments
  2. Novartis Pharmaceuticals Corporation $553 24 payments
  3. Neurocrine Biosciences, Inc. $470 28 payments
  4. TG Therapeutics, Inc. $402 17 payments
  5. Jazz Pharmaceuticals Inc. $393 18 payments
  6. SK Life Science, Inc. $391 18 payments
  7. ACADIA Pharmaceuticals Inc $388 19 payments
  8. Lundbeck LLC $364 16 payments
  9. Otsuka America Pharmaceutical, Inc. $353 16 payments
  10. Pfizer Inc. $287 16 payments
  11. Other $2,570 125 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $7,042 380 payments
  2. Education $90 1 payment
Products named General payments · program years 2023–2025
  1. QULIPTA $646 68 payments
  2. UBRELVY $610 66 payments
  3. KESIMPTA $553 24 payments
  4. INGREZZA $470 28 payments
  5. BRIUMVI $402 17 payments
  6. NUPLAZID $388 19 payments
  7. XYWAV $303 17 payments
  8. Leqembi $296 14 payments
  9. NURTEC ODT $287 16 payments
  10. ZAVZPRET $287 16 payments
  11. Other $3,599 170 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

381 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record